Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 Variants
: These results highlight the potential of this PapMV-N vaccine to induce broad protection against diverse SARS-CoV-2 variants.
Authors
- Santa-Mariela Olivera-Ugarte
- Marilène Bolduc
- Darryl Falzarano (ORCID: https://orcid.org/0000-0002-8805-8068)
- Mariana Baz (ORCID: https://orcid.org/0000-0002-1230-0735)
- Caroline Garneau
- Denis Leclerc (ORCID: https://orcid.org/0000-0002-9323-1638)
- Louis Flamand (ORCID: https://orcid.org/0000-0001-5010-4586)
- Tekeleselassie Woldemariam
- Henintsoa Rabezanahary
- Jean-François Lemay
- Mitra Yousefi
- Rong Shi
- Léa-J. Blanchette (ORCID: https://orcid.org/0009-0001-5788-0921)
- Myriam Angers
- Silvia Vidal
Institutions
- Collège Shawinigan (CA)
- University of Saskatchewan (CA)
- Centre National en Électrochimie et en Technologies Environnementales (CA)
- William Osler Health System (CA)
- Université Laval (CA)
Publication Details
- Journal
- Vaccines
- Published
- 2026-04-15
- DOI
- https://doi.org/10.3390/vaccines14040349
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Université Laval
- Centre Hospitalier Universitaire de Québec
- Canadian Institutes of Health Research